PER 1.27% 8.0¢ percheron therapeutics limited

From the annual report 2023..."As of week, ending 30 June 2023,...

  1. 271 Posts.
    lightbulb Created with Sketch. 521


    From the annual report 2023...

    "As of week, ending 30 June 2023, 16 (of 40) doses had been administered and tolerated. Dosing of all animals is on track
    to be completed by December 2023 with study outcomes expected to be reported in the first half of 2024. Successful completion of the toxicology study is necessary for the FDA to allow dosing of ATL1102 for a term longer than six months in the US."


 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.